Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

A 7-year-old vaccine that has drastically cut intestinal infections in infants is benefiting the rest of America, too.

A study published Tuesday from the Centers for Disease Control and Prevention shows that vaccinating infants against rotavirus has also caused a striking decline in serious infections among older children and adults who didn't get vaccinated.

The Centers for Disease Control and Prevention says 300,000 Americans are getting Lyme disease every year, and the toll is growing.

"It confirms what we've thought for a long time: This is a large problem," Dr. Paul Mead tells Shots. "The bottom line is that by defining how big the problem is we make it easier for everyone to figure out what kind of resources we have to use to address it."

A study of women in Costa Rica is raising hope that getting vaccinated against the human papillomavirus, or HPV, could lower the risk of throat cancers.

The research doesn't show that. It would take a much bigger and longer study to do that – if such a study could ethically be done at all.

What this study does show is that among the nearly 6,000 women in the study, those who got vaccinated against two strains of the virus had 93 percent fewer HPV throat infections four years later.

A vaccine against human papillomavirus — the most common sexually transmitted infection and the cause of almost all cervical cancer — is dramatically reducing the prevalence of HPV in teenage girls.

The first vaccine against HPV, Merck's Gardasil, was approved by the Food and Drug Administration in 2006. Cerverix, from GlaxoSmithKline, was approved in 2009.

It's been eight months since a Saudi Arabian doctor described a previously unknown virus related to SARS. And for most of that time only germ geeks paid much attention.

But in the past few days the new virus — which some would like to call MERS-CoV, for Middle East Respiratory Syndrome Coronavirus — has been making up for lost time.

The work is only in mice so far, but it sure is intriguing.

A newly found hormone revs up production of cells that make insulin — the very kind that people with advanced diabetes lack.

Boston hospitals always staff up their emergency rooms on Marathon Day to care for runners with cramps, dehydration and the occasional heart attack.

But Monday, those hospitals suddenly found themselves with more than 100 traumatized patients — many of them with the kinds of injuries seen more often on a battlefield than a marathon.

Like most big-city hospitals these days, Tufts Medical Center runs regular disaster drills, featuring simulated patients smeared with fake blood.

Sixteen cases of a new flu around Shanghai have touched off a major effort to determine what kind of threat this new bug might be.

The victims range in age from 4 to 87 years old. Six have died. It is a tragedy for them and their families, but is it a global crisis?

To understand why so few cases are generating so much concern, the first thing to know is that no flu virus like this one — called H7N9 — has ever been known to infect humans before.

It's not the first study that finds the lowly aspirin may protect against the deadliest kind of skin cancer, but it is one of the largest.

And it adds to a mounting pile of studies suggesting that cheap, common aspirin lowers the risk of many cancers — of the colon, breast, esophagus, stomach, prostate, bladder and ovary.

The World Health Organization says a new coronavirus has killed two people in Jordan — the third country where the novel microbe has been traced.

That brings lab-confirmed cases to nine, with five fatalities.

It's a troubling story authorities think will unfold over the next month or so. An untold number of Americans who got steroid injections in their spine to relieve back pain may end up with a rare fungal meningitis. The drug was contaminated with the spores of a common leaf mold — nobody knows how.

So far, the Centers for Disease Control and Prevention has recorded 35 cases of the fungal meningitis in six states: Tennessee, North Carolina, Florida, Virginia, Maryland and Indiana. Five patients have died.

Scientists have known for a while that breast cancer is really four different diseases, with subtypes among them, an insight that has helped improve treatment for some women.

But experts haven't understood much about how these four types differ. A new report, published online in the journal Nature, provides a big leap in that understanding.

Scientists have found solid evidence that older men have more random mutations in their sperm cells. They're warning that can cause autism, schizophrenia and a long list of other genetic diseases in their offspring.

The new report, in the journal Nature, comes from deCODE Genetics, an Icelandic firm that studied the entire genomes of 78 families involving 219 individuals.

America's oldest citizens are generally getting healthier, living longer and doing better financially. But there's lots of room for improvement.

That's the take-home from an exhaustive picture of Americans over 65 put together by the federal government and released last week during the summer doldrums.

The so-called Berlin patient is famously the only person in the world who has been cured of HIV. But he may soon have company.

Two people in Boston also seem to be free of HIV after undergoing bone marrow transplants for cancer, just as the Berlin patient did five years ago. The crucial difference is that the Boston patients have not yet stopped taking anti-HIV drugs — although that may happen in the coming months.

A highly resistant form of a common bacterium recently popped up in two Rhode Island patients, only the 12th and 13th times it has been spotted in this country.

Top AIDS scientists are scratching their heads about new data from the most famous HIV patient in the world — at least to people in the AIDS community.

Timothy Ray Brown, known as the Berlin patient, is thought to be the first patient ever to be cured of HIV infection.

A shortage of Adderall began last year, sending millions of people with attention deficit/hyperactivity disorder and narcolepsy on perpetual wild goose chases to find drugstores with the pills they need to stay alert and focused.

So it's not surprising that Adderall counterfeiters have seized a big marketing opportunity. What is surprising is their clumsiness.

Tuberculosis specialists in India have diagnosed infections in a dozen patients in Mumbai that are unfazed by the three first-choice TB drugs and all nine second-line drugs.

The doctors are calling them "totally drug-resistant TB," and the infections are essentially incurable with all available medicines.

Federal officials say they're making headway in their push to stem abuse of addictive painkillers. Still, they say, U.S. doctors are prescribing enough narcotics to medicate every American around the clock for a month.

The Centers for Disease Control and Prevention says drug overdoses may soon overtake car crashes as the nation's leading cause of fatal injury.

Pages